Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

Blood (2019) 134 (Supplement_1): 1944.

https://doi.org/10.1182/blood-2019-125276

Published: 2019

Journal Articles

CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity

Tim Sauer, MD, Kathan Parikh, Sandhya Sharma, Bilal Omer, MD, Stephen Gottschalk, MD, Cliona M. Rooney, PhD

Blood (2019) 134 (Supplement_1): 1932.

https://doi.org/10.1182/blood-2019-125534

Published: 2019

Journal Articles

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study

Blood (2019) 134 (Supplement_1): 2058.

https://doi.org/10.1182/blood-2019-126746

Published: 2019

Journal Articles

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency

Blood (2019) 134 (Supplement_1): 608.

https://doi.org/10.1182/blood-2019-127439

Published: 2019

Journal Articles

Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML Activity

Hong Mu-Mosley, MD PhD, Lauren B Ostermann, Muharrem Muftuoglu, MD, Wendy Schober, Nalini B Patel, Abishek Vaidya, MS, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD, Michael Andreeff, MD PhD

Blood (2019) 134 (Supplement_1): 3917.

https://doi.org/10.1182/blood-2019-125928

Published: 2019

Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 4441.

https://doi.org/10.1182/blood-2019-125395

Published: 2019

Journal Articles

Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia

Abdullah Freiwan, MSc, Abishek Vaidya, MS, Caitlin Zebley, MD, Yiping Fan, PhD, Deanna Langfitt, PhD, Benjamin Youngblood, PhD, Maksim Mamonkin, PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 868.

https://doi.org/10.1182/blood-2019-124903

Published: 2019

Journal Articles

A Single Intramuscular Injection of AAV-8 Vector Expressing MDA7/IL-24 Efficiently Suppresses Tumor Growth Mediated by Multiple Anti-Cancer Mechanisms In Lymphoma Model Mice.

Nanya Wang, MD, Bai Fan, MD, Noriko Miyake, PhD, Koichi Miyake, MD, PhD, Takashi Shimada, MD, PhD

Blood (2010) 116 (21): 1474.

https://doi.org/10.1182/blood.V116.21.1474.1474

Published: 2010

Journal Articles

Tumor Homing Activity of Bone Marrow-Derived Mesenchymal Stem Cell Is Highly Various Among Different Tumors On Syngeneic Mouse Model Using Real-Time in Vivo Imaging Technique.

Su-Peng Yeh, Wen-Jyi Lo, Yu-Chien Chang, Wan-Ju Tsai, Chiao-Lin Lin, Yu-Min Liao, MD

Blood (2009) 114 (22): 1453.

https://doi.org/10.1182/blood.V114.22.1453.1453

Published: 2009

Journal Articles

Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.

Catherine A Taylor, John A. Lust, MD, PhD, Bin Ye, Zhongda Liu, Zhong Sun, Richard S. Dondero, PhD, Bruce Galton, Kathleen A. Donovan, Ph.D., John E. Thompson

Blood (2009) 114 (22): 2462.

https://doi.org/10.1182/blood.V114.22.2462.2462

Published: 2009

Journal Articles

Retroviral Vector-Producing Mesenchymal Stem Cells for Tumor Tracking and Therapeutic Gene Amplification in Suicide Cancer Gene Therapy.

Ryosuke Uchibori, Takashi Okada, MD, PhD, Takayuki Ito, MD, PhD, Masashi Urabe, MD, PhD, Hiroaki Mizukami, MD, PhD, Akihiro Kume, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2007) 110 (11): 1917.

https://doi.org/10.1182/blood.V110.11.1917.1917

Published: 2007

Journal Articles

An Improved, Non-Viral Approach for Production of hCD40L + B-CLL Cells for Cancer Immunotherapy.

Linhong Li, PhD, Cornell Allen, MS, Stephanie Feller, MS, Larry Wolfraim, PhD, Angelia Viley, MS, Joseph C. Fratantoni, MD, Linda N. Liu, PhD

Blood (2006) 108 (11): 2107.

https://doi.org/10.1182/blood.V108.11.2107.2107

Published: 2006

Journal Articles

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

Manuel Schmidt, Javier de Christobal, Nicole Hagner, Astrid Sander, Alberto Marco, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 3915.

https://doi.org/10.1182/blood.V106.11.3915.3915

Published: 2005

Journal Articles

Tumor cells escape suicide gene therapy by genetic and epigenetic instability

Oliver Frank, Cornelia Rudolph, Christoph Heberlein, Nils von Neuhoff, Evelin Schröck, Axel Schambach, Brigitte Schlegelberger, Boris Fehse, Wolfram Ostertag, Carol Stocking, Christopher Baum

Blood (2004) 104 (12): 3543–3549.

https://doi.org/10.1182/blood-2004-03-0852

Published: 2004

Journal Articles

Intratumoral Expression of MIP-1b Induces Antitumor Responses in a Pre-Established Tumor Model through Chemoattracting T Cells and NK Cells.

Yizhi Yu, Xiaoling Luo, Shuxun Liu, Yuan Xie, Xuetao Cao

Blood (2004) 104 (11): 5268.

https://doi.org/10.1182/blood.V104.11.5268.5268

Published: 2004

Journal Articles

Blood Outgrowth Endothelial Cells (BOEC) Contribute to Tumor Vascularization and Can Be Used for Delivery of Cancer Gene Therapy.

Arkadiusz Z. Dudek, MD, PhD, Vidya Bodempudi, PhD, Curtis M. Nelson, Liming Chang, PhD, Robert P. Hebbel, MD

Blood (2004) 104 (11): 3173.

https://doi.org/10.1182/blood.V104.11.3173.3173

Published: 2004

Journal Articles

Selective and Efficient Gene Delivery of CD40-Ligand by a Fiber-Modified Adenovirus Vector with Specific Antibody to Human Leukemia and Myeloma.

Kazunori Kato, PhD, Sachie Hirai, Yukari Masuta, Aiko Kuroishi, Kiminori Nakamura, PhD, DDS, Hirofumi Hamada, MD, PhD

Blood (2004) 104 (11): 5263.

https://doi.org/10.1182/blood.V104.11.5263.5263

Published: 2004

NARROW

Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency

Transgenic Expression of IL15 in CD123-Specific BiTE-Secreting Engager T-Cells Results in Improved Anti-AML Activity

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia

A Single Intramuscular Injection of AAV-8 Vector Expressing MDA7/IL-24 Efficiently Suppresses Tumor Growth Mediated by Multiple Anti-Cancer Mechanisms In Lymphoma Model Mice.

Tumor Homing Activity of Bone Marrow-Derived Mesenchymal Stem Cell Is Highly Various Among Different Tumors On Syngeneic Mouse Model Using Real-Time in Vivo Imaging Technique.

Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.

Retroviral Vector-Producing Mesenchymal Stem Cells for Tumor Tracking and Therapeutic Gene Amplification in Suicide Cancer Gene Therapy.

An Improved, Non-Viral Approach for Production of hCD40L + B-CLL Cells for Cancer Immunotherapy.

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

Tumor cells escape suicide gene therapy by genetic and epigenetic instability

Intratumoral Expression of MIP-1b Induces Antitumor Responses in a Pre-Established Tumor Model through Chemoattracting T Cells and NK Cells.

Blood Outgrowth Endothelial Cells (BOEC) Contribute to Tumor Vascularization and Can Be Used for Delivery of Cancer Gene Therapy.

Selective and Efficient Gene Delivery of CD40-Ligand by a Fiber-Modified Adenovirus Vector with Specific Antibody to Human Leukemia and Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only